2013 Parkinson's Study Group Symposium

第27届帕金森病的病因、发病机制和治疗研讨会 帕金森病和其他运动障碍 主要研究人员：Michael Schwarzschild，医学博士 摘要 帕金森研究小组(PSG)与亨廷顿研究小组(HSG)合作， 肌张力障碍研究组(DSG)、抽动症研究组(TSSG)、协作性共济失调 中国地震学会(CAG)和地震研究学会(TRG)将举办第27届震颤研究年会 帕金森氏病和其他运动障碍的病因、发病机制和治疗 2013年10月1日，星期二，在加拿大蒙特利尔的费尔蒙伊丽莎白女王酒店。 同行评审计划包括平台和海报演示，以现场形式提供 观众参与。研讨会将讨论运动障碍的最新问题。 主旨演讲运动障碍功能神经外科的临床试验设计 关于包括帕金森在内的运动障碍的同行评议平台和海报演示 疾病，亨廷顿病，肌萎缩症，共济失调和震颤。主题旨在 交流最新研究进展，包括新的药理和非 运动障碍领域的药物治疗选择，从而提高患者 关心。临床实践中需要解决的差距是与翻译有关的未满足的需求 和临床研究，以及对受影响的患者和家庭的护理和治疗 运动障碍。研讨会结束时，与会者应能够：1) 讨论功能性药物临床试验研究设计的方法和挑战 帕金森病及相关运动障碍的神经外科治疗；2)讨论 神经外科治疗多发性肌萎缩侧索硬化症的新进展和新领域 帕金森病和相关疾病；3)描述特征、护理方面的差异 不同的帕金森病人口和临床亚群的模式和结果 对研究和护理的影响；4)确定与临床护理相关的伦理问题和 涉及运动障碍的功能神经外科治疗的研究；以及5)讨论 肌张力障碍、共济失调、震颤和其他运动障碍的最新治疗进展。

27th Annual Parkinson Study Group Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders Principal Investigator: Michael Schwarzschild, MD, PhD Abstract The Parkinson Study Group (PSG), in collaboration with the Huntington Study Group (HSG), Dystonia Study Group (DSG), Tourette Syndrome Study Group (TSSG), Cooperative Ataxia Group (CAG), and Tremor Research Group (TRG), will present the 27th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders on Tuesday, October 1, 2013, at Fairmont The Queen Elizabeth Hotel, in Montreal, Canada. The peer-reviewed program includes both platform and poster presentations in a live format with audience participation. The symposium will consist of current issues in movement disorders with keynote talks on clinical trial design for functional neurosurgery of movement disorders and peer-reviewed platform and poster presentations on movement disorders including Parkinson disease, Huntington disease, Dystonia, Ataxia, and Tremor. Topics are designed to communicate recent research advances, including new pharmacological and non- pharmacological treatment options in the field of movement disorders thereby enhancing patient care. The gaps in clinical practice to address are the unmet needs pertaining to the translational and clinical research, along with the care and treatment of patients and families affected by movement disorders. At the conclusion of the symposium, participants should be able to: 1) Discuss approaches and challenges to study designs for clinical trials of functional neurosurgical treatments of Parkinson disease and related movement disorders; 2) Discuss recent advances and new frontiers in the neurosurgical approaches to management of Parkinson disease and related disorders; 3) Describe differences in characteristics, care patterns, and outcomes across different PD demographic and clinical subpopulations and their implications on research and care; 4) Identify ethical issues associated with clinical care and research involving functional neurosurgical treatments of movement disorders; and 5) Discuss recent treatment advances in dystonia, ataxia, tremor, and other movement disorders.